Tom C. Hobman

University of Alberta — Canada

Medicine · Health Sciences

45h-index5.8kcitations145works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(38), Virology and Viral Diseases(36), Viral Infections and Vectors(26), RNA Research and Splicing(19), interferon and immune responses(19)

Publications145 total

FGFR signaling and neddylation facilitate SARS-CoV-2 infection by modulating interferon induction and viral entry, respectively
iScience·2025Open Access
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening
Viruses·2025Open Access
Exposure to ZIKA viral particles is sufficient to induce GSDME-mediated syncytiotrophoblast pyroptosis
Placenta·2025
Expanding knowledge of mosquito (Diptera: Culicidae) and California serogroup viruses distributions in the North American Arctic
Journal of Medical Entomology·2025Open Access
Potent broad-spectrum anti-coronaviral frameshift inhibitors from virtual screen of RNA binding
2025Open Access
Peroxisomes as emerging clinical targets in neuroinflammatory diseases
Frontiers in Molecular Neuroscience·2025· 1 citedOpen Access
Immunometabolism perturbations in post-COVID-19 condition: interleukin-6 and monoamine oxidase interactions drive neuropsychiatric syndromes
Brain Behavior and Immunity·2025· 3 cited
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April–July 2024)
Viral Immunology·2025
Angiostatin—a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology
Journal of Thrombosis and Haemostasis·2025
No Evidence of Anti-influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April – July 2024)
2025Open Access
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses
Nature Biomedical Engineering·2024· 5 cited
First Confirmed Report of Jamestown Canyon Virus in Greenland
Journal of Medical Virology·2024· 3 citedOpen Access
Longitudinal screening of retail milk from Canadian provinces reveals no detections of influenza A virus RNA (April–July 2024): leveraging a newly established pan-Canadian network for responding to emerging viruses
Canadian Journal of Microbiology·2024· 11 citedOpen Access
Longitudinal Influenza A Virus Screening of Retail Milk from Canadian Provinces (Rolling Updates)
2024· 5 citedOpen Access
SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport
Molecular Biology of the Cell·2024· 8 citedOpen Access
The Wnt/β-catenin pathway is important for replication of SARS-CoV-2 and other pathogenic RNA viruses
npj Viruses·2024· 19 citedOpen Access
The domestication of SARS-CoV-2 into a seasonal infection by viral variants
Frontiers in Microbiology·2023· 1 citedOpen Access
Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease
Journal of Biological Chemistry·2023· 12 citedOpen Access
MicroRNA-25/93 induction by Vpu as a mechanism for counteracting MARCH1-restriction on HIV-1 infectivity in macrophages
mBio·2023· 8 citedOpen Access
Special Issue of the 4th Symposium of the Canadian Society for Virology 2022
Viruses·2023Open Access
page 1 of 8Next →

Frequent Co-authors

Anil Kumar(10), Zaikun Xu(7), Shangmei Hou(5), Adriana M. Airo(5), Daniel Limonta(5), Christopher Power(5), Lara K. Mahal(5), Nasser Tahbaz(5), Marilyn G. Farquhar(5), William G. Branton(4), Mohamed Elaish(4), Joaquín López-Orozco(4), L. Woodward(4), Martin D. Beatch(4), Matt D. Urbanowski(3), Shirley Gillam(3), Jon B. Carmichael(3), Valeria Mancinelli(2), James A. Wells(2), Steven Willows(2)